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Introduction 
     Clostridium difficile (CD) is an 
infectious disease that has a direct 
impact on our healthcare resources. 
“Clostridium difficile, an anaerobic, 
spore forming, toxin-forming, gram-
positive bacillus, has become the leading 
cause of health care—associated 
infectious diarrhea (Walters & 
Zuckerbraun, 2014, p. 329).” I chose 
this topic because CD is a hypervirulent 
organism that is not only affecting 
hospitalized patients but is now 
emerging as a community acquired 
infection. Healthcare treatments and 
costs are on the rise due to persistent 
and recurrent CD infections. 
Understanding the pathogenesis, risk 
factors, diagnostic testing, and 
management strategies are important in 
reducing the spread of CD infections 
(Keske &Letizia 2010). 
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Additional Sources 
Significance of Pathophysiology 
Clostridium difficile (CD) is a spore-forming microorganism that releases toxins 
when in an anaerobic environment. The spore form allows the bacteria to remain 
dormant until the opportune conditions cause the bacteria to emerge. The CD spore, 
after ingested, is resistant to gastric acid and can be passed into the intestines, where 
conditions are favorable. The spores then germinate and release two exotoxins, A and 
B, that contain properties of enterotoxins and cytotoxins. These toxins can open tight 
junctions between cells in the intestines that end with increased vascular permeability 
and hemorrhaging (Fraser & Swiencicki, 2015). The toxins also produce tumor 
necrosis factor-alpha and proinflammatory interleukins that cause an inflammatory 
response that leads to the development of pseudomembranes. Toxins A and B cause 
tissue damage in the gastrointestinal tract which results in diarrhea. CD is able to 
colonize in the gastrointestinal tract following a change in normal flora. The change in 
normal flora is typically caused by antibiotic use. Antibiotics kill off the body’s normal 
flora in the intestines providing more nutrients and space for the remaining infectious 
microorganism like CD.  
 
• Asymptomatic (carrier) 
• Watery diarrhea (at least three   
         bowel movements per day for 
         two or more days) 
•  Fever 
•  Loss of appetite 
•  Nausea 
•  Abdominal pain/cramping  
• Dehydration 
 
 
 
 
 
 
     The significance of the pathophysiology of CD is its highly virulent factors. The 
spore form is what makes this organism resistant and highly transmissible. 
Healthcare workers pose the greatest risk of transference from direct or indirect 
exposure to a patient or their patient’s environment. Understanding CD, it’s 
transmission, and its infectious process will allow for adequate treatment. According 
to Juneau et al. (2015), “approximately 20% of patients with CDI develop a recurrent 
episode of C. difficile colitis, typically within 3-10 days after completing antibiotics” 
(p. 4). The etiology of CD recurrence is not currently well understood. It could be 
related to inadequate eradication following the antibiotic regimen or it may be related 
to inadequate production of antibodies against the bacterial toxins (Juneau et al., 
2015). More research is needed to identify recurrence rates to better compare 
community acquired verse hospital acquired CD infections.  
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Figure 2. What does C. difficile do to the gut? 
Figure 4 Untitled photograph of a compliance sign on contact precautions 
There are many unknown factors about CD infections that need further 
investigation. More research is needed to further evaluate its epidemiology, risk 
factors, diagnostic measures, control measures, and treatment options (Juneau et al., 
2013). Prevention is key in controlling the spread of this hospital-acquired or 
community-acquired infection. Nurses play a critical role in the prevention of CD 
infections through early detection, patient education, implementing contact 
precautions, and assisting with environmental cleanliness and surveillance.  
Conclusion 
Figure 1. Medical Illustration of 
 Clostridium     
  
Risk Factors 
1. Early identification and diagnosis  
 
2. Implementation of contact isolation precautions (gown and gloves are important to  
prevent spore transmission) 
 
3. Private room (separate stethoscopes and blood pressure cuffs) 
 
4. Proper cleansing and care of environmental factors to stop transmission 
 
5. Cautious hand hygiene with soap and water is necessary to adequately remove 
 spores and prevent transmission (Alcohol based hand gels are ineffective in 
 removing spores) 
 
6. Focused antimicrobial stewardship programs 
 
7. Earlier surgical consultations and management may improve outcomes in patients   
 with a complicated disease 
 
8. A multidisciplinary approach with the support of hospital leaders is needed to 
 reduce the morbidity, mortality, and financial burden for patients and the health care 
 system. 
 
9. Avoid unnecessary use of antibiotics 
Implications for Nursing Care 
Figure 3. Untitled photograph of Clostridium difficile disease process  
 
• Exposure to organism 
• Prolonged hospitalization 
• Older age 
• Comorbidities (inflammatory bowel disease, gastrointestinal surgery, cancer, 
chemotherapy treatment, and organ transplant)  
• Immunosuppressive patients 
• Severity of illness 
• Malnutrition 
• Male sex 
• Recent or frequent use of broad-spectrum antibiotics 
• Use of proton pump inhibitors may also be a risk factor  
Underlying Pathophysiology 
Signs & Symptoms 
